Unlock stock picks and a broker-level newsfeed that powers Wall Street.
323.98
-7.25
(-2.19%)
At close: April 1 at 4:00:01 PM EDT
320.51
-3.47
(-1.07%)
Pre-Market: 4:11:50 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 16 | 14 |
| Avg. Estimate | -3.76 | -3.2 | -12.58 | 1.74 |
| Low Estimate | -5.04 | -5.43 | -21.21 | -14.7 |
| High Estimate | -2.71 | -1.19 | -4.76 | 18.76 |
| Year Ago EPS | -7.38 | -7.1 | -21.9 | -12.58 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 16 | 14 |
| Avg. Estimate | 112.79M | 137.84M | 586.19M | 1.04B |
| Low Estimate | 96.82M | 118M | 487.42M | 751.1M |
| High Estimate | 132M | 158M | 685.3M | 1.33B |
| Year Ago Sales | -- | 14.64M | 180.13M | 586.19M |
| Sales Growth (year/est) | 0.00% | 841.68% | 225.42% | 78.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -6.39 | -7.66 | -6.91 | -4.12 |
| EPS Actual | -7.38 | -7.1 | -4.92 | -2.71 |
| Difference | -0.99 | 0.56 | 1.99 | 1.41 |
| Surprise % | -15.43% | 7.33% | 28.80% | 34.30% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -3.76 | -3.2 | -12.58 | 1.74 |
| 7 Days Ago | -3.71 | -3.06 | -12.58 | 1.74 |
| 30 Days Ago | -3.75 | -3.32 | -13.53 | 2.55 |
| 60 Days Ago | -3.62 | -3.13 | -12.93 | 2.81 |
| 90 Days Ago | -3.83 | -3.25 | -13.37 | 2.47 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | 6 | 4 |
| Up Last 30 Days | 3 | 3 | 5 | 5 |
| Down Last 7 Days | 2 | 2 | 3 | 3 |
| Down Last 30 Days | 3 | 3 | 6 | 4 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MDGL | 49.06% | 54.89% | 42.55% | 113.81% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Maintains | Citigroup: Buy to Buy | 2/27/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/27/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 1/14/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 1/10/2025 |
| Reiterates | Cantor Fitzgerald: Neutral | 11/20/2024 |
| Maintains | B. Riley Securities: Neutral to Neutral | 11/5/2024 |
Related Tickers
AKRO Akero Therapeutics, Inc.
38.64
-4.55%
SRRK Scholar Rock Holding Corporation
30.06
-6.50%
VKTX Viking Therapeutics, Inc.
23.91
-0.99%
AXSM Axsome Therapeutics, Inc.
111.67
-4.25%
VRNA Verona Pharma plc
58.54
-7.80%
SWTX SpringWorks Therapeutics, Inc.
41.88
-5.10%
BBIO BridgeBio Pharma, Inc.
33.02
-4.48%
ETNB 89bio, Inc.
6.80
-6.53%
APLS Apellis Pharmaceuticals, Inc.
22.68
+3.70%
INCY Incyte Corporation
60.91
+0.59%